Although there are numerous reports describing an increase in nonocular hemorrhagic events, blood pressure elevation, myocardial infarction, and kidney disease after anti-VEGF therapy,33C36 none of these reports include information regarding the systemic VEGF-A levels. the follow-up. Patients in the treatment groups were older than the healthy controls (= 0.001; the KruskalCWallis test) but did not […]